Thermo Fisher to add sterile filling lines in Singapore

By The Science Advisory Board staff writers

October 14, 2020 -- Thermo Fisher Scientific will operate a $130 million facility in Singapore that will be used to develop two new sterile filling lines, extending capacity to develop and manufacture therapies and vaccines.

The facility, which was supported by the Singapore Economic Development Board, will include a high-speed sterile line approved for live virus filling and an additional line for standard filling and finishing. When it opens in 2022, it also will have cleanroom capacity, labs, warehousing, and offices to support production. The facility is expected to manufacture up to 30 million sterile doses per month, according to the company.

The facility is being built to meet pharmaceutical product demand in the Asia-Pacific region and to respond more effectively to future health emergencies, like COVID-19.

Thermo Fisher debuts clinical research grant program
Thermo Fisher Scientific introduced a clinical research grant program to support health projects in oncology and reproductive health.
Thermo Fisher expands plastics production to support COVID-19 efforts
Thermo Fisher Scientific is investing an additional $140 million to further expand its laboratory plastics consumables production to support the...
Thermo Fisher center forms partnerships for biomarkers
Thermo Fisher Scientific announced new collaborations for clinical biomarker discovery among the Thermo Fisher Precision Medicine Science Center, AstraZeneca,...
Thermo Fisher opens new bioprocessing collaboration center
Thermo Fisher Scientific has opened a new bioprocessing collaboration center in St. Louis to accelerate innovations in biologics manufacturing.
Thermo Fisher to manufacture Inovio's COVID-19 vaccine
Thermo Fisher Scientific has signed a letter of intent to manufacture Inovio's DNA COVID-19 vaccine candidate, INO-4800.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter